🔬 Science 3d ago

FDA approves Dupixent for chronic spontaneous urticaria in young children

Medical Xpress
Medical Xpress health science
View Channel →
FDA approves Dupixent for chronic spontaneous urticaria in young children
Source ↗ 👁 0 💬 0
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's Dupixent (dupilumab) for the treatment of children (aged 2 to 11 years) with chronic spontaneous urticaria (CSU).

Comments (0)

Sign in to join the discussion

More Like This

Pentagon unveils trove of declassfied 'UFO' videos. How to see them all, from 'a football-shaped body' to 'a misshapen and uneven ball of white light'
Latest from Space.com · 10h ago
Black holes slamming into scorching stars may be causing mysterious blue flashes in the cosmos
Latest from Space.com · 11h ago
Monopoly sucks, but this new 'Star Wars' video game spinoff might add some galactic sizzle
Latest from Space.com · 13h ago
US government releases huge batch of UFO files
New Scientist - Home · 13h ago
How you'd really die in space: What sci-fi gets right (and wrong) about extra-terrestrial expirations
Latest from Space.com · 14h ago
This is your best chance to spot the Milky Way's core in May
Latest from Space.com · 15h ago